Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
ZM008 Alone and With Pembrolizumab for Cancer
Recruiting1 awardPhase 1
Austin, Texas
This trial is testing a new drug called ZM008 in patients with advanced solid tumors who have already tried standard treatments or cannot tolerate them. The drug will be given alone at first and then in combination
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service